Best hospitals for heart failure: A data-based guide to evaluating specialized care

This guide examines how hospitals distinguish themselves in heart-failure care, including multidisciplinary treatment, advanced therapies, quality recognition, transplant services, and disease-management programs. It also explains why location, insurance, eligibility, clinical complexity, and long-term follow-up matter when comparing hospitals.

For readers researching the best hospitals for heart failure, there is no single universally accepted national list. A meaningful comparison requires examining specialty expertise, quality measures, advanced-treatment capability, transplant services, coordinated follow-up, location, and insurance participation.

How “best” is defined in heart-failure care

Heart failure includes conditions in which the heart cannot pump or fill adequately, and care needs vary substantially by disease stage and cause. Penn Medicine describes treatment spanning early prevention, chronic management, advanced heart failure, clinical trials, and second opinions, while its hospitals hold Joint Commission Gold Seal of Approval recognition for Advanced Heart Failure. 2 These distinctions indicate that hospital suitability depends on whether a patient needs routine medication management, complex diagnostic evaluation, device therapy, or transplant assessment.

Quality recognition is one useful comparison point, but it is not a complete ranking. Deborah Heart and Lung Center received a U.S. News & World Report 2026-2027 High Performing designation for heart failure, a distinction the hospital describes as the highest available within the publication’s Procedures & Conditions ratings. Fewer than half of the hospitals evaluated earned a High Performing designation in the care categories assessed. 1 Patients still need to consider the specific service required and whether the recognition applies to that service.

Hospitals with documented heart-failure recognition

Several hospital systems in the supplied research report formal quality or specialty credentials. Hackensack Meridian Health said eight of its medical centers received the American Heart Association’s 2025 Get With The Guidelines-Heart Failure Gold Plus Award, with Target: Heart Failure and Target: Type 2 Diabetes Honor Roll recognition. The listed hospitals included Hackensack University Medical Center, Jersey Shore University Medical Center, JFK University Medical Center, Bayshore, Ocean, Palisades, Riverview, and Southern Ocean medical centers. 7

Hospital or systemDocumented distinction or capability
Deborah Heart and Lung CenterU.S. News High Performing for heart failure in 2026-2027
Penn MedicineJoint Commission advanced-heart-failure recognition at several hospitals
Hackensack Meridian Health hospitalsAmerican Heart Association Gold Plus awards at eight medical centers
UT Health TylerAmerican Heart Association Heart Failure Gold Plus award in 2026

UT Health Tyler received the American Heart Association’s Heart Failure Gold Plus quality-achievement award in August 2026. The award tiers range from Bronze through Gold Plus and are based on achievement of at least 85 percent of specified association guidelines. The reported goals include evidence-based treatment, shorter hospital stays, improved outcomes, and more healthy days at home. 8 Such awards evaluate care processes and adherence to guidelines, rather than guaranteeing an identical result for every patient.

Large academic and advanced-care programs

The research identifies Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Brigham and Women’s Hospital, Cedars-Sinai, Duke Health, Johns Hopkins Medicine, UPMC, and NewYork-Presbyterian as institutions with dedicated or advanced heart-failure services. Reported capabilities include multidisciplinary evaluation, disease-management programs, medication optimization, ventricular-assist-device assessment, mechanical circulatory support, transplantation, and clinical research. 11 12 13 14

These programs are generally most relevant when heart failure is complex, progressive, or difficult to control with standard treatment. Cleveland Clinic’s described services include medical care, device therapy, mechanical circulatory support, and transplantation, while Massachusetts General Hospital emphasizes coordinated disease management. Brigham and Women’s describes evaluation for ventricular-assist devices and transplantation, and Duke Health reports medical, procedural, surgical, and transplant-related care. 12 13 14

Multidisciplinary hospital team reviewing heart-failure care and cardiac imaging
Multidisciplinary hospital team reviewing heart-failure care and cardiac imaging

Regional programs and specialized referral services

Regional hospitals can provide important heart-failure expertise without being national referral centers. OU Health describes a multidisciplinary program in Oklahoma City and Edmond involving board-certified cardiologists and other specialists, with evaluation for specific, advanced, and rare forms of heart failure. Its reported services may include ventricular-assist devices, cardiac transplantation, and multi-organ transplantation when clinically appropriate. 5

Montefiore Einstein reports that its cardiology service acts as a referral site for heart failure, arrhythmia, and mechanical circulatory support, and describes a heart-transplantation program serving the tri-state area. UTMB likewise treats all types of heart failure, including cases involving fluid accumulation, irregular rhythms, heart pumps, or transplantation. 3 4 The availability of a referral pathway may matter when local cardiology care needs to be connected with advanced specialists.

Advanced therapies, eligibility, and ongoing care

Advanced heart-failure treatment is not automatically appropriate for every patient. UTMB lists possible management involving medications, lifestyle changes, aquapheresis, left ventricular assist-device implantation, and transplantation, while UPMC’s described program includes medication optimization, implanted devices, ventricular-assist devices, and transplant evaluation. 4 18 Eligibility depends on clinical assessment, disease severity, coexisting conditions, testing, surgical risk, and the judgment of the treating team.

  • Medication plans may require repeated adjustment and monitoring.
  • Implanted devices and ventricular-assist devices involve procedures, follow-up, and potential complications.
  • Transplant programs require formal evaluation and continuing specialty care.
  • Remote monitoring and clinical trials may be available at selected centers.

UCSF describes remote monitoring initiatives, device and therapy research, and care for patients who may require ventricular-assist devices or transplantation. Penn Medicine also reports clinical trials and second-opinion services as components of its heart-failure program. 9 2 These options can expand clinical choices, but they also introduce eligibility requirements, travel considerations, research protocols, and long-term maintenance responsibilities.

Practical comparison factors and safety considerations

A hospital comparison should begin with the patient’s immediate clinical question: diagnosis confirmation, chronic disease management, hospitalization recovery, rhythm treatment, device assessment, or advanced-heart-failure referral. The hospital’s ability to coordinate cardiology, surgery, transplantation, rehabilitation, and follow-up may be more relevant than a broad institutional reputation. Insurance participation and appointment logistics also require direct verification because provider networks and accepted plans can change. 10

Heart failure can involve severe shortness of breath, fatigue, swelling, rapid or irregular heartbeat, low blood pressure, confusion, or loss of consciousness. UTMB identifies cardiogenic shock as a critical condition requiring immediate treatment and describes symptoms including rapid breathing, weak pulse, cold clammy skin, and confusion. 4 A hospital-selection article cannot replace emergency assessment. For ongoing care, patients should compare documented quality measures, specialist credentials, advanced-therapy pathways, communication practices, travel demands, coverage, and the requirements for continuing monitoring.

Sources

  1. Deborah Heart and Lung Center
  2. Penn Medicine
  3. Montefiore Einstein
  4. UTMB Health
  5. OU Health
  6. Mary Washington Healthcare
  7. Patch, reporting on Hackensack Meridian Health
  8. Tyler Morning Telegraph, reporting on UT Health Tyler
  9. UCSF Health
  10. Columbia University Irving Medical Center
  11. Mayo Clinic
  12. Cleveland Clinic
  13. Massachusetts General Hospital
  14. Brigham and Women’s Hospital
  15. MedStar Health
  16. Cedars-Sinai
  17. Duke Health
  18. UPMC
  19. Johns Hopkins Medicine
  20. NewYork-Presbyterian

Authored by MyTrendSpot team